Recently Added Courses

Current Evidence-based Management of Idiopathic Pulmonary Fibrosis: Collaborating To Improve Patient Care

Start Activity

Advances in Radioactive Iodine-Refractory Differentiated Thyroid Cancer

Start Activity

Reducing Stroke Risk in Atrial Fibrillation Patients: The Critical Role of Oral Anticoagulation

Start Activity

Treatment Strategies in Chronic Leukemias and Introduction to CAR-T Therapy

Start Activity

Evidence-based Updates in Non-Hodgkin’s Lymphoma

Start Activity

Evidence-based Updates in Non-Hodgkin’s Lymphoma

Credits 1.00 (60 min)

Format Slides

Basic Concepts and Evolution of Biosimilars in Patient Therapy: Implication for Pharmacy Management

Start Activity

Use of Oncology Quality Measures Where Do We Go from Here?

Start Activity

HRCT and the Radiologist’s Role in Diagnosing IPF

Start Activity

HRCT and the Radiologist’s Role in Diagnosing IPF

Credits 0.75 (45 min)

Format Slides

Current Evidence-based Management of Idiopathic Pulmonary Fibrosis: Collaborating To Improve Patient Care

Start Activity

Advances in Radioactive Iodine-Refractory Differentiated Thyroid Cancer

Start Activity

Reducing Stroke Risk in Atrial Fibrillation Patients: The Critical Role of Oral Anticoagulation

Start Activity

Treatment Strategies in Chronic Leukemias and Introduction to CAR-T Therapy

Start Activity

Evidence-based Updates in Non-Hodgkin’s Lymphoma

Start Activity

Evidence-based Updates in Non-Hodgkin’s Lymphoma

Credits 1.00 (60 min)

Format Slides

Basic Concepts and Evolution of Biosimilars in Patient Therapy: Implication for Pharmacy Management

Start Activity

Use of Oncology Quality Measures Where Do We Go from Here?

Start Activity

HRCT and the Radiologist’s Role in Diagnosing IPF

Start Activity

HRCT and the Radiologist’s Role in Diagnosing IPF

Credits 0.75 (45 min)

Format Slides

Oncology

The Transition from Biologics to Biosimilars in Oncology Treatment Paradigms: A Means to Reduce Healthcare Costs with Continued Effective Management of Patients

Start Activity

Use of Novel Combination Therapies in the Treatment of Advanced HR+/HER2‐ Breast Cancer

Start Activity

Integrating New Therapies into Treatment Regimens for Gastric and Gastroesophageal Cancer

Start Activity

Optimizing the Use of Novel Agents for the Treatment of Leukemia

Start Activity

Optimizing the Use of Novel Agents for the Treatment of Leukemia

Credits 1.00 (60 min)

Format Live Meeting

Advances in Radioactive Iodine-Refractory Differentiated Thyroid Cancer

Start Activity

Integrating New Therapies into Treatment Regimens for Gastric and Gastroesophageal Cancer

Start Activity

Optimizing the Use of Novel Agents for the Treatment of Leukemia

Start Activity

Precision Medicine and Impact of Therapeutic Drug Levels

Start Activity

Precision Medicine and Impact of Therapeutic Drug Levels

Credits 0.75 (45 min)

Format Slides

The Transition from Biologics to Biosimilars in Oncology Treatment Paradigms: A Means to Reduce Healthcare Costs with Continued Effective Management of Patients

Start Activity

Use of Novel Combination Therapies in the Treatment of Advanced HR+/HER2‐ Breast Cancer

Start Activity

Integrating New Therapies into Treatment Regimens for Gastric and Gastroesophageal Cancer

Start Activity

Optimizing the Use of Novel Agents for the Treatment of Leukemia

Start Activity

Optimizing the Use of Novel Agents for the Treatment of Leukemia

Credits 1.00 (60 min)

Format Live Meeting

Advances in Radioactive Iodine-Refractory Differentiated Thyroid Cancer

Start Activity

Integrating New Therapies into Treatment Regimens for Gastric and Gastroesophageal Cancer

Start Activity

Optimizing the Use of Novel Agents for the Treatment of Leukemia

Start Activity

Precision Medicine and Impact of Therapeutic Drug Levels

Start Activity

Precision Medicine and Impact of Therapeutic Drug Levels

Credits 0.75 (45 min)

Format Slides

Courses by Topic

At Glance

With more than 50 currently available courses; 200,000 overall learners (and growing!); and 20+ years of experience and excellence in medical education, Rockpointe is the preferred partner for quality CME!